Literature DB >> 25609413

Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE.

Jens Y Humrich1, Caroline von Spee-Mayer1, Elise Siegert1, Tobias Alexander1, Falk Hiepe1, Andreas Radbruch2, Gerd-Rüdiger Burmester1, Gabriela Riemekasten1.   

Abstract

Entities:  

Keywords:  Cytokines; Systemic Lupus Erythematosus; T Cells; Treatment

Mesh：

Substances：

Year:  2015        PMID： 25609413     DOI： 10.1136/annrheumdis-2014-206506

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  68 in total

1.  Immune regulation of kidney disease in 2015: Updates on immunosuppression in kidney disease.

Authors:  Hans-Joachim Anders
Journal:  Nat Rev Nephrol       Date:  2015-12-14       Impact factor: 28.314

Review 2.  T cells in Systemic Lupus Erythematosus.

Authors:  Abel Suárez-Fueyo; Sean J Bradley; George C Tsokos
Journal:  Curr Opin Immunol       Date:  2016-09-13       Impact factor: 7.486

3.  Regulatory T Cells: Concept, Classification, Phenotype, and Biological Characteristics.

Authors:  Yang Du; Qiannan Fang; Song-Guo Zheng
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Dying to protect: cell death and the control of T-cell homeostasis.

Authors:  Kun-Po Li; Sharmila Shanmuganad; Kaitlin Carroll; Jonathan D Katz; Michael B Jordan; David A Hildeman
Journal:  Immunol Rev       Date:  2017-05       Impact factor: 12.988

5.  Clinical trials: The rise of IL-2 therapy - a novel biologic treatment for SLE.

Authors:  Jens Y Humrich; Gabriela Riemekasten
Journal:  Nat Rev Rheumatol       Date:  2016-10-20       Impact factor: 20.543

6.  Interleukin-2 treatment reverses effects of cAMP-responsive element modulator α-over-expressing T cells in autoimmune-prone mice.

Authors:  K Ohl; A Wiener; A Schippers; N Wagner; K Tenbrock
Journal:  Clin Exp Immunol       Date:  2015-05-14       Impact factor: 4.330

Review 7.  Beyond pan-B-cell-directed therapy - new avenues and insights into the pathogenesis of SLE.

Authors:  Thomas Dörner; Peter E Lipsky
Journal:  Nat Rev Rheumatol       Date:  2016-10-13       Impact factor: 20.543

8.  Retinoic acid-induced autoantigen-specific type 1 regulatory T cells suppress autoimmunity.

Authors:  Mathilde Raverdeau; Maria Christofi; Anna Malara; Mieszko M Wilk; Alicja Misiak; Lucia Kuffova; Tian Yu; Aoife M McGinley; Shauna M Quinn; Chandirasegaran Massilamany; Jay Reddy; John V Forrester; Kingston Hg Mills
Journal:  EMBO Rep       Date:  2019-03-20       Impact factor: 8.807

9.  [IL-2-Therapy in SLE- Selective reconstitution of immunological tolerance].

Authors:  J Y Humrich; G Riemekasten
Journal:  Z Rheumatol       Date:  2016-06       Impact factor: 1.372

Review 10.  Empowering Regulatory T Cells in Autoimmunity.

Authors:  Isaac R Kasper; Sokratis A Apostolidis; Amir Sharabi; George C Tsokos
Journal:  Trends Mol Med       Date:  2016-07-25       Impact factor: 11.951
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.